The Take Home
HCV Next, May/June 2018
Nancy S. Reau, MD
As we in the United States look ahead to Digestive Disease Week coming up and further to our fall meetings, the International Liver Congress gives us…
Editorial
HCV Next, May/June 2018
Ira M. Jacobson, MD
This month’s issue has a very nice summary of the data on therapeutic regimens presented at the International Liver Congress by Nancy S. Reau…
Meeting NewsVideo
April 25, 2018
PARIS — In this exclusive interview from the International Liver Congress 2018, Mani Subramanian, PhD, discusses innovative approaches to…
Meeting NewsVideo
April 24, 2018
PARIS — In this exclusive interview from the International Liver Congress 2018, Mani Subramanian, PhD, provides an update on Gilead’s…
Meeting News
April 24, 2018
PARIS — Reduced serum bile acids after treatment with the ileal bile acid transporter inhibitor A4250 correlated with reductions in autotaxin…
Meeting News
April 23, 2018
Findings presented at the International Liver Congress suggest that point-of-care testing for hepatitis C virus infection in community clinics in…
Meeting NewsVideo
April 23, 2018
PARIS —Chairman of the department of medicine at Inova Fairfax Hospital, Virginia, Zobair M. Younossi, MD, discusses results of two studies on…
Meeting NewsVideo
April 23, 2018
PARIS — Results from a real-world cohort of patients with hepatitis C treated with Mavyret showed a sustained virologic response of 97%…
Meeting News
April 20, 2018
PARIS — Rapid improvement in albumin levels after 4 weeks of treatment with direct-acting antivirals for hepatitis C significantly predicted…
Meeting NewsVideo
April 20, 2018
PARIS — In this exclusive interview from the International Liver Congress 2018, Christophe Hezode, MD, discusses positive study results from…